Injectables and Fillers

Top Story

Questions raised about evidence for FDA approval of soft-tissue fillers

July 19, 2017

Despite FDA approval based largely on randomized clinical trial results, questions about the safety of soft-tissue fillers prompted a recent retrospective investigation.

The researchers conducted the systematic review to evaluate the level of evidence required for FDA approval of soft-tissue fillers. Specifically, they investigated risks for blindness and facial necrosis associated with off-label use of the devices.

Worldwide demand for cosmetic surgery continues dramatic increases

July 14, 2017
The International Society of Aesthetic Plastic Surgery published results of the annual Global Aesthetic Survey that showed a 9% overall increase in surgical and…

Nearly 70% of surveyed consumers considering cosmetic procedures

June 28, 2017
Almost 70% of consumers reported that they are considering a cosmetic procedure, according to survey results released by the American Society for Dermatologic Surgery…
In the Journals

DaxibotulinumtoxinA shows greater efficacy, response duration vs. Botox

June 28, 2017
Injectable daxibotulinumtoxinA, an investigational botulinum toxin Type A, showed superior efficacy and duration of response in certain doses over Botox and placebo at…
More Headlines »
Advertisement
Advertisement